210 related articles for article (PubMed ID: 18574467)
1. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.
Lukasiak S; Schiller C; Oehlschlaeger P; Schmidtke G; Krause P; Legler DF; Autschbach F; Schirmacher P; Breuhahn K; Groettrup M
Oncogene; 2008 Oct; 27(46):6068-74. PubMed ID: 18574467
[TBL] [Abstract][Full Text] [Related]
2. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers.
Lee CG; Ren J; Cheong IS; Ban KH; Ooi LL; Yong Tan S; Kan A; Nuchprayoon I; Jin R; Lee KH; Choti M; Lee LA
Oncogene; 2003 May; 22(17):2592-603. PubMed ID: 12730673
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adenovirus encoding FAT10 small interfering RNA inhibits HCC growth in vitro and in vivo.
Chen J; Yang L; Chen H; Yuan T; Liu M; Chen P
Exp Mol Pathol; 2014 Apr; 96(2):207-11. PubMed ID: 24440736
[TBL] [Abstract][Full Text] [Related]
4. p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers.
Zhang DW; Jeang KT; Lee CG
Oncogene; 2006 Apr; 25(16):2318-27. PubMed ID: 16501612
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of gene expression relative to 18S rRNA in carcinoma samples using the LightCycler instrument and a SYBR GreenI-based assay: determining FAT10 mRNA levels in hepatocellular carcinoma.
Lukasiak S; Breuhahn K; Schiller C; Schmidtke G; Groettrup M
Methods Mol Biol; 2008; 429():59-72. PubMed ID: 18695959
[TBL] [Abstract][Full Text] [Related]
6. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
7. FAT10, a ubiquitin-independent signal for proteasomal degradation.
Hipp MS; Kalveram B; Raasi S; Groettrup M; Schmidtke G
Mol Cell Biol; 2005 May; 25(9):3483-91. PubMed ID: 15831455
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
[TBL] [Abstract][Full Text] [Related]
9. FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences.
Canaan A; Yu X; Booth CJ; Lian J; Lazar I; Gamfi SL; Castille K; Kohya N; Nakayama Y; Liu YC; Eynon E; Flavell R; Weissman SM
Mol Cell Biol; 2006 Jul; 26(13):5180-9. PubMed ID: 16782901
[TBL] [Abstract][Full Text] [Related]
10. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
11. GRP78 Promotes Hepatocellular Carcinoma proliferation by increasing FAT10 expression through the NF-κB pathway.
Luo C; Xiong H; Chen L; Liu X; Zou S; Guan J; Wang K
Exp Cell Res; 2018 Apr; 365(1):1-11. PubMed ID: 29458176
[TBL] [Abstract][Full Text] [Related]
12. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
Schmidtke G; Kalveram B; Groettrup M
FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.
Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ
Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617
[TBL] [Abstract][Full Text] [Related]
14. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
[TBL] [Abstract][Full Text] [Related]
15. The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functions.
Schregle R; Mah MM; Mueller S; Aichem A; Basler M; Groettrup M
Immunogenetics; 2018 Jul; 70(7):429-438. PubMed ID: 29508036
[TBL] [Abstract][Full Text] [Related]
16. FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells.
Gao Y; Theng SS; Zhuo J; Teo WB; Ren J; Lee CG
Carcinogenesis; 2014 Apr; 35(4):923-34. PubMed ID: 24325913
[TBL] [Abstract][Full Text] [Related]
17. Induction of alpha1-acid glycoprotein mRNA by cytokines and differentiation in human colon carcinoma cell.
Lee Y; Lim JW; Kim YM; Lee IH; Choi YC; Park KC
Mol Cells; 2001 Apr; 11(2):164-9. PubMed ID: 11355696
[TBL] [Abstract][Full Text] [Related]
18. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis.
Tsuchiya N; Ochiai M; Nakashima K; Ubagai T; Sugimura T; Nakagama H
Cancer Res; 2007 Oct; 67(19):9568-76. PubMed ID: 17909068
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin-like modifier FAT10 is required for normal IFN-γ production by activated CD8
Mah MM; Basler M; Groettrup M
Mol Immunol; 2019 Apr; 108():111-120. PubMed ID: 30818228
[TBL] [Abstract][Full Text] [Related]
20. FAT10 mediates the effect of TNF-α in inducing chromosomal instability.
Ren J; Wang Y; Gao Y; Mehta SB; Lee CG
J Cell Sci; 2011 Nov; 124(Pt 21):3665-75. PubMed ID: 22025632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
